CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income (loss)	$ 474	$ 837
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred income taxes	(57)	203
Provision for inventories	33	13
Depreciation and amortization	61	68
Amortization and write-off of capitalized software development costs and intellectual property licenses	131	140
Amortization of debt discount and debt financing costs	5	0
Stock-based compensation expense	74	76
Excess tax benefits from stock awards	(29)	(14)
Changes in operating assets and liabilities:
Accounts receivable, net	(193)	498
Inventories	(90)	(116)
Software development and intellectual property licenses	(253)	(212)
Other assets	59	99
Deferred revenues	(54)	(1,008)
Accounts payable	(83)	(56)
Accrued expenses and other liabilities	19	(144)
Net cash provided by operating activities	97	384
Cash flows from investing activities:
Proceeds from maturities of available-for-sale investments	21	295
Proceeds from sale of available-for-sale investments	0	60
Purchases of available-for-sale investments	0	(26)
Capital expenditures	(90)	(58)
Decrease in restricted cash	(11)	(9)
Deposit in escrow	0	(71)
Net cash (used in) provided by investing activities	(80)	191
Cash flows from financing activities:
Proceeds from issuance of common stock to employees	160	92
Tax payments related to net share settlements on restricted stock rights	(41)	(19)
Excess tax benefits from stock awards	29	14
Dividends paid	(147)	(216)
Repayment of long-term debt	(375)	0
Net cash used in financing activities	(374)	(129)
Effect of foreign exchange rate changes on cash and cash equivalents	(248)	39
Net (decrease) increase in cash and cash equivalents	(605)	485
Cash and cash equivalents at beginning of period	4,410	3,959
Cash and cash equivalents at end of period	$ 3,805	$ 4,444